What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Michael R. Zile focuses on Internal medicine, Cardiology, Heart failure, Ejection fraction and Heart failure with preserved ejection fraction.
His Internal medicine research incorporates themes from Endocrinology and Surgery.
His Cardiology research incorporates elements of Angiotensin receptor and Intensive care medicine.
His Heart failure research is multidisciplinary, incorporating perspectives in Valsartan, Enalapril and Diastole.
He interconnects Irbesartan, Clinical endpoint, Randomized controlled trial, Cause of death and Hazard ratio in the investigation of issues within Ejection fraction.
He has included themes like Spironolactone, Pulmonary hypertension and Atrial fibrillation in his Heart failure with preserved ejection fraction study.
His most cited work include:
- Angiotensin-neprilysin inhibition versus enalapril in heart failure. (2773 citations)
- Irbesartan in patients with heart failure and preserved ejection fraction (1312 citations)
- Diastolic Heart Failure — Abnormalities in Active Relaxation and Passive Stiffness of the Left Ventricle (1184 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Ejection fraction and Heart failure with preserved ejection fraction.
In most of his Internal medicine studies, his work intersects topics such as Endocrinology.
As a part of the same scientific study, he usually deals with the Endocrinology, concentrating on Matrix metalloproteinase and frequently concerns with Extracellular matrix.
His work deals with themes such as Irbesartan and Blood pressure, which intersect with Cardiology.
Michael R. Zile works mostly in the field of Heart failure, limiting it down to topics relating to Randomized controlled trial and, in certain cases, Baroreflex.
His studies in Ejection fraction integrate themes in fields like Diabetes mellitus, Natriuretic peptide, Surgery and Atrial fibrillation.
He most often published in these fields:
- Internal medicine (96.20%)
- Cardiology (76.73%)
- Heart failure (63.37%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (96.20%)
- Heart failure (63.37%)
- Cardiology (76.73%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Heart failure, Cardiology, Ejection fraction and Heart failure with preserved ejection fraction are his primary areas of study.
His research combines Diabetes mellitus and Internal medicine.
His work in Heart failure covers topics such as Atrial fibrillation which are related to areas like Left ventricular hypertrophy.
His study in the field of Paradigm hf, Cardiac resynchronization therapy and Sudden death is also linked to topics like In patient.
His Ejection fraction study which covers Heart rate that intersects with Renal function, Digoxin and Dialysis.
His Heart failure with preserved ejection fraction study integrates concerns from other disciplines, such as Irbesartan, Clinical trial, Coronary artery disease, Exercise intolerance and Myocardial infarction.
Between 2018 and 2021, his most popular works were:
- Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. (72 citations)
- Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure (71 citations)
- Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure (71 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Gene
His primary areas of study are Heart failure, Internal medicine, Ejection fraction, Cardiology and Heart failure with preserved ejection fraction.
Michael R. Zile has researched Heart failure in several fields, including Valsartan and Randomized controlled trial.
Michael R. Zile usually deals with Internal medicine and limits it to topics linked to Diabetes mellitus and Aliskiren and MEDLINE.
His Ejection fraction study combines topics in areas such as Blood pressure, Randomization, Hazard ratio, Socioeconomic status and Sudden cardiac death.
His work on Pulmonary hypertension as part of general Cardiology research is frequently linked to Value, thereby connecting diverse disciplines of science.
His studies deal with areas such as Sudden death, Coronary artery disease, Quality of life, Prediabetes and New York Heart Association Functional Classification as well as Heart failure with preserved ejection fraction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
